Diverse Regulation of Cardiac Expression of Relaxin Receptor by α1- and β1-Adrenoceptors
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diverse Regulation of Cardiac Expression of Relaxin Receptor by α1- and β1-Adrenoceptors
Authors
Keywords
Relaxin family peptide receptor-1 (RXFP1), Adrenoceptors, Cardiomyocyte
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume 28, Issue 3, Pages 221-228
Publisher
Springer Nature
Online
2014-05-22
DOI
10.1007/s10557-014-6525-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epac2 Mediates Cardiac β1-Adrenergic–Dependent Sarcoplasmic Reticulum Ca 2+ Leak and Arrhythmia
- (2013) Laëtitia Pereira et al. CIRCULATION
- Relaxin Suppresses Atrial Fibrillation by Reversing Fibrosis and Myocyte Hypertrophy and Increasing Conduction Velocity and Sodium Current in Spontaneously Hypertensive Rat Hearts
- (2013) Ashish Parikh et al. CIRCULATION RESEARCH
- Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
- (2013) M. Metra et al. EUROPEAN HEART JOURNAL
- Relaxin Family Peptides and Their Receptors
- (2013) R. A. D. Bathgate et al. PHYSIOLOGICAL REVIEWS
- Benefits of blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
- (2013) S. Chatterjee et al. BMJ-British Medical Journal
- Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
- (2012) John R Teerlink et al. LANCET
- Novel Role of Platelets in Mediating Inflammatory Responses and Ventricular Rupture or Remodeling Following Myocardial Infarction
- (2011) Yang Liu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Progesterone Withdrawal, and Not Increased Circulating Relaxin, Mediates the Decrease in Myometrial Relaxin Receptor (RXFP1) Expression in Late Gestation in Rats1
- (2010) Lenka A. Vodstrcil et al. BIOLOGY OF REPRODUCTION
- Myocardial oxidative stress contributes to transgenic β2-adrenoceptor activation-induced cardiomyopathy and heart failure
- (2010) Q Xu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Relaxin
- (2010) Jason Grossman et al. Cardiology in Review
- Relaxin Therapy Reverses Large Artery Remodeling and Improves Arterial Compliance in Senescent Spontaneously Hypertensive Rats
- (2010) Qi Xu et al. HYPERTENSION
- Unveiling the Vasodilatory Actions and Mechanisms of Relaxin
- (2010) Kirk P. Conrad HYPERTENSION
- The Positive Inotropic Effect of Relaxin-2 in Human Atrial Myocardium is Preserved in End-Stage Heart Failure: Role of Gi-Phosphoinositide-3 Kinase Signaling
- (2010) Thomas Dschietzig et al. JOURNAL OF CARDIAC FAILURE
- β-Arrestin: A signaling molecule and potential therapeutic target for heart failure
- (2010) Nabila Noor et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Alpha-1-adrenergic receptors: Targets for agonist drugs to treat heart failure
- (2010) Brian C. Jensen et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- α1-Adrenergic Activation Upregulates Expression of Relaxin Receptor RXFP1 in Cardiomyocytes
- (2009) Xiao-Lei Moore et al. Annals of the New York Academy of Sciences
- Intravenous Recombinant Human Relaxin in Compensated Heart Failure: A Safety, Tolerability, and Pharmacodynamic Trial
- (2009) Thomas Dschietzig et al. JOURNAL OF CARDIAC FAILURE
- Cardiovascular effects of relaxin: from basic science to clinical therapy
- (2009) Xiao-Jun Du et al. Nature Reviews Cardiology
- A Novel Protein Kinase A-independent, β-Arrestin-1-dependent Signaling Pathway for p38 Mitogen-activated Protein Kinase Activation by β2-Adrenergic Receptors
- (2008) Kaizheng Gong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started